Harada, Kenji
Kario, Kazuomi
Article History
Received: 12 October 2021
Accepted: 19 October 2021
First Online: 24 November 2021
Compliance with ethical standards
:
: KH has no conflicts of interest to disclose. KK reports scholarships from Daiichi Sankyo, Sumitomo Dainippon Pharma, Otsuka Pharmaceuticals, and Takeda Pharmaceuticals and honoraria from Daiichi Sankyo and Novartis Pharma outside the submitted work.
Free to read: This content has been made available to all.